Release Date: 23/11/17 11:41 Summary: Appointment of Director - Mr Jason Smith Price Sensitive: No Download Document 251.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%